BioNTech has entered into a licencing agreement with MediLink Therapeutics for ...
The European Medicines Agency’s Committee for Medicinal Products for Human Use ...
Amneal Pharmaceuticals and mAbxience have entered into an exclusive licensing a...
As the healthcare landscape undergoes transformation due to factors like aging ...
When is a billion-dollar deal a bad omen? Has Wall Street gone overboard on Ozem...
This brain map is essentially a cellular “parts list” of the human brain and a g...
In the latest edition of STAT's Health Tech newsletter: Better Therapeutics data...
Want to stay on top of the science and politics driving biotech today? Sign up t...
Both the number of deals and the amount of money being invested in life science ...
The EU in 2022 ruled that the purchase violated antitrust rules, and Thursday’s ...
Centering mothers and families in the care of preterm infants and keeping mother...
The second installment of STAT's rural health series explores why rural residenc...
Peter Marks wants drug developers to ask more stupid questions. It’s part of the...
It’s no secret that biotech industry funding has fallen from its Covid highs. Bu...
As AdvaMed concludes, here are the key takeaways from the world’s largest medica...
A company that Pfizer blamed for problems with a clinical trial testing a Lyme v...